FDA

Latest Stories

FILE - In this Thursday, April 8, 2021 file photo, the Johnson &amp; Johnson COVID-19 vaccine sits on a table at a pop up vaccinations site the Albanian Islamic Cultural Center, in the Staten Island borough of New York. The U.S. is recommending a “pause” in administration of the single-dose Johnson &amp; Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. (AP Photo/Mary Altaffer, File)

US recommends ‘pause’ for J&J shots in blow to vaccine drive

By ZEKE MILLER and LAURAN NEERGAARD and MATTHEW PERRONE - Associated Press

All Maryland residents 16 and up to be vaccine eligible

By BRIAN WITTE - Associated Press

In this March 25, 2021, file photo, a box of the Johnson &amp; Johnson COVID-19 vaccine is shown in a refrigerator at a clinic in Washington state. A batch of Johnson &amp; Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said late Wednesday, March 31, 2021. The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries. (AP Photo/Ted S. Warren)

Company producing J&J vaccine had history of violations

By RICHARD LARDNER and JASON DEAREN and LINDA A. JOHNSON - Associated Press

In 17 brands of supplements, researchers found nine prohibited stimulants that were mixed into eight different combinations (Associated Press)

Diet, sports supplements use banned ingredients, study finds

By Shen Wu Tan - The Washington Times

A young girl looks out the window of her room in the pediatric unit of the Robert Debre hospital, in Paris, France, Tuesday, March 2, 2021. A year into the coronavirus pandemic, increasing numbers of children are coming apart at the seams, their mental health shredded by the traumas of deaths, sickness and job losses in their families, the disruptions of lockdowns and curfews, and a deluge of anxieties poisoning their fragile young minds. (AP Photo/Christophe Ena)

The Latest: US health officials warn of false positives

By The Associated Press - Associated Press

This July 2020 photo provided by Johnson &amp; Johnson shows a vial of the COVID-19 vaccine in Belgium. The U.S. is getting a third vaccine to prevent COVID-19, as the Food and Drug Administration on Saturday, Feb. 27, 2021 cleared a Johnson &amp; Johnson shot that works with just one dose instead of two.(Johnson &amp; Johnson via AP, File)

J&J’s 1-dose shot cleared, giving US 3rd COVID-19 vaccine

By LAURAN NEERGAARD and MATTHEW PERRONE - Associated Press

Illustration: FCC's broadband by Alexander Hunter for The Washington Times

Why I’m challenging the FCC about antiquated safety standards for wireless devices

By Devra Davis

FILE - In this Jan. 22, 2021, file photo, empty vials of the Pfizer-BioNTech COVID-19 vaccine are seen at a vaccination center at the University of Nevada, Las Vegas, in Las Vegas. The makers of COVID-19 vaccines are figuring out how to tweak their recipes against worrisome virus mutations — if and when the shots need an update. (AP Photo/John Locher, File)

COVID-19 shots might be tweaked if variants get worse

By LAURAN NEERGAARD - Associated Press

German drug firm to pay $50M in US purity case at India site

By KEN RITTER - Associated Press

In this Dec. 10, 2020, file photo, Food and Drug Administration building is shown in Silver Spring, Md. (AP Photo/Manuel Balce Ceneta, File) ** FILE **

Baby foods contain toxic heavy metals: report

By Shen Wu Tan - The Washington Times

President Joe Biden speaks about the coronavirus in the State Dinning Room of the White House, Thursday, Jan. 21, 2021, in Washington. (AP Photo/Alex Brandon)

Joe Biden faces pressure to aim higher in COVID-19 vaccine goals

By Tom Howell Jr. - The Washington Times

FILE - This Nov. 15, 1995 file photo shows then Food and Drug Administration (FDA) Administrator David Kessler testifying on Capitol Hill in Washington. President-elect Joe Biden has picked Kessler to lead vaccine science in his drive to put 100 million shots into the arms of Americans in his administration's first 100 days and stem the COVID-19 pandemic. (AP Photo/Denis Paquin)

Biden taps former FDA chief Kessler to lead vaccine science

By RICARDO ALONSO-ZALDIVAR and MATTHEW PERRONE - Associated Press

In this Jan. 2, 2021, file photo, a person completes a swab of their mouth at a Curative walk-up kiosk testing site for COVID-19 at the Garfield Community Center in Seattle. The U.S. Food and Drug Administration is warning patients and health care providers that a coronavirus test developed by California company Curative may produce false results. (AP Photo/Ted S. Warren, File)

Congress, LA take divergent paths after COVID test warning

By BRIAN MELLEY and MATTHEW PERRONE - Associated Press

EXPLAINER: US regulator weighs in on vaccine dosing debate

By LAURAN NEERGAARD - Associated Press

Chicken Kitchen owner Julio Salazar, left, buys hand sanitizer from Chainbridge Distillery owner Bela Nahori in Oakland Park, Fla., on Tuesday, Aug. 11, 2020. The local distillery was given FDA approval to stop making spirits and instead make hand sanitizer at the start of the pandemic, but the demand has since plummeted and Nahori is currently overstocked. (John McCall /South Florida Sun-Sentinel via AP)

HHS overturns plan to slap $14,000 fee on distilleries who helped combat COVID

By Stephen Dinan - The Washington Times

FILE - In this July 27, 2020, file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. The U.S. is poised to give the green light as early as Friday, Dec. 18, to a second COVID-19 vaccine, a critical new weapon against the surging coronavirus. Doses of the vaccine developed by Moderna Inc. and the National Institutes of Health will give a much-needed boost to supplies as the biggest vaccination effort in the nation’s history continues. (AP Photo/Hans Pennink, File)

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

By LAURAN NEERGAARD and MATTHEW PERRONE - Associated Press

FILE - A man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers of new cases, hospitalizations and deaths ahead of more holiday travel and family gatherings. FDA's OK is expected shortly after the all-day meeting concludes. (AP Photo/Bill Sikes, file)

FDA plans to OK 2nd COVID-19 vaccine after panel endorsement

By MATTHEW PERRONE and LAURAN NEERGAARD - Associated Press

In this file photo, a man stands outside an entrance to a Moderna, Inc., building, Monday, May 18, 2020, in Cambridge, Mass. A second COVID-19 vaccine moved closer to joining the U.S. fight against the pandemic Thursday, Dec. 17, 2020 as government experts convened for a final public review of its safety and effectiveness. The shot from Moderna and the National Institutes of Health is urgently needed as the country continues to record ever-higher numbers of new cases, hospitalizations and deaths ahead of more holiday travel and family gatherings. FDA's OK is expected shortly after the all-day meeting concludes. (AP Photo/Bill Sikes, file) **FILE**

FDA panel takes up Moderna COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

A droplet falls from a syringe after a health care worker was injected with the Pfizer-BioNTech COVID-19 vaccine at Women &amp; Infants Hospital in Providence, R.I., Tuesday, Dec. 15, 2020. (AP Photo/David Goldman)

Health officials track safety as COVID-19 vaccines roll out

By LAURAN NEERGAARD - Associated Press

Colleen Teevan, System Pharmacy Clinical Manager at Hartford HealthCare, administers the Pfizer-BioNTech vaccine for COVID-19 to healthcare worker Connor Paleski outside of Hartford Hospital, Monday, Dec. 14, 2020, in Hartford, Conn. (AP Photo/Jessica Hill)

US vaccinations ramp up as 2nd COVID-19 shot nears

By Matthew Perrone and Lauran Neergaard - Associated Press